METROPOLITAN LIFE INSURANCE CO/NY - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 88 filers reported holding DESIGN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$12,701
+9.2%
2,0160.0%0.00%0.0%
Q1 2023$11,632
-49.6%
2,016
-10.4%
0.00%0.0%
Q4 2022$23,075
-31.9%
2,249
+11.0%
0.00%
-50.0%
Q3 2022$33,891
+19.4%
2,0270.0%0.00%
+100.0%
Q2 2022$28,378
-13.3%
2,0270.0%0.00%0.0%
Q1 2022$32,736
-81.0%
2,027
-74.8%
0.00%
-50.0%
Q4 2021$172,3088,0480.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders